Metastatic Colorectal Cancer - PEAK Study - NATIONWIDE
(Clinical Trial 6180)
URL for your blog or website:
http://www.ClinicalConnection.com/6180.aspx
|
|
Scroll down to search
for clinics conducting this clinical trial.
|
| Location: |
|
NATIONWIDE |
|
|
|
|
|
|
|
|
|
| Study
summary: |
|
Individuals with colorectal cancer that has metastasized (spread) are invited to inquire about participation in a clinical research study. This study will evaluate an investigational fully human monoclonal antibody combined with chemotherapy to see if it will extend survival for a longer period of time, compared to the best available standard of care regimen. Monoclonal antibodies are substances produced in a laboratory that can locate and bind to cancer cells by recognizing specific substances on cancer cells. These antibodies are used to find and attack tumors.
|
| Qualified participants must: |
|
Have unresectable (inoperable) colorectal cancer that has metastasized (spread)
Be at least 18 years of age;
Not have received a prior treatment regimen for their advanced-stage colorectal cancer
Meet other enrollment criteria
|
| Participants will receive: |
|
Study-related medication and study-related procedures at no cost
|
| Study is
available at: |
|
This study is being conducted
NATIONWIDE! To find clinics conducting this study near you please use search
feature below. |
|
|